[Results of Paveron 75 therapy in negatively selected patients with cerebral function disorders].
D001205:Ascorbic Acid / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008722:Methods; D009025:Morpholines / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use*; D012431:Rutin / Q000627:therapeutic use
D009025:Morpholines; D012431:Rutin; D010208:Papaverine; D001205:Ascorbic Acid
Ergebnisse der Therapie mit Paveron 75 an einer Negativauslese von Patienten mit zerebralen Funktionsstörungen.